Immune Health

News Watch

Research & Practice

Observational studies in humans have shown that early life exposure to microbes in a variety of situations is associated with a decreased risk of asthma. These include: - Exposure of a pregnant mother to microbes in order to protect her baby - Exposure of children to livestock or dogs - Growing up with numerous siblings Meanwhile, disruption of normal colonization…

Mary Ellen Sanders
Mary Ellen Sanders is a consultant in the area of probiotic microbiology, with special expertise on paths to scientific substantiation of probiotic product label claims. Dr. Sanders served as the founding president of the International Scientific Association for Probiotics and Prebiotics (ISAPP) and is currently the organization’s Director of Scientific Affairs/ Executive Officer. This international, non-profit association of academic and industrial scientists is dedicated to advancing the science of probiotics and prebiotics (www.isapp.net). Through numerous written, oral and video pieces, including a website, www.usprobiotics.org, she strives to provide objective, evidence-based information on probiotics for consumers and professionals. Key activities include: Panels to determine GRAS status of probiotic strains ; member of the American Gastroenterological Association Scientific Advisory Board for AGA Center for Gut Microbiome Research and Education ; World Gastroenterology Organisation Committee preparing practice guidelines for the use of probiotics and prebiotics for GI indications (2008, 2011, 2014) ; working group convened by the FAO/WHO that developed guidelines for probiotics (2002).

Observational studies in humans have shown that early life exposure to microbes in a variety of situations is associated with a decreased risk of asthma. These include: - Exposure of a pregnant mother to microbes in order to protect her baby - Exposure of children to livestock or dogs - Growing up with numerous siblings Meanwhile, disruption of normal colonization…

Mary Ellen Sanders
Mary Ellen Sanders is a consultant in the area of probiotic microbiology, with special expertise on paths to scientific substantiation of probiotic product label claims. Dr. Sanders served as the founding president of the International Scientific Association for Probiotics and Prebiotics (ISAPP) and is currently the organization’s Director of Scientific Affairs/ Executive Officer. This international, non-profit association of academic and industrial scientists is dedicated to advancing the science of probiotics and prebiotics (www.isapp.net). Through numerous written, oral and video pieces, including a website, www.usprobiotics.org, she strives to provide objective, evidence-based information on probiotics for consumers and professionals. Key activities include: Panels to determine GRAS status of probiotic strains ; member of the American Gastroenterological Association Scientific Advisory Board for AGA Center for Gut Microbiome Research and Education ; World Gastroenterology Organisation Committee preparing practice guidelines for the use of probiotics and prebiotics for GI indications (2008, 2011, 2014) ; working group convened by the FAO/WHO that developed guidelines for probiotics (2002).

Dr. Jonathan Braun (MD, PhD) is a physician and researcher interested in how the immune system affects susceptibility to inflammatory bowel disease and cancer. He studies, among other things, microbial-immune commensalism in the intestine, and new strategies in functional immune assessment. He is a professor at UCLA's David Geffen School of Medicine. At the 2014 Harvard Probiotics Symposium, GMFH interviewed…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

Dr. Jonathan Braun (MD, PhD) is a physician and researcher interested in how the immune system affects susceptibility to inflammatory bowel disease and cancer. He studies, among other things, microbial-immune commensalism in the intestine, and new strategies in functional immune assessment. He is a professor at UCLA's David Geffen School of Medicine. At the 2014 Harvard Probiotics Symposium, GMFH interviewed…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

TH17 (T helper 17) has emerged as a novel potential therapeutic agent for the control of intestinal inflammatory conditions. These cells are most abundant in the small intestinal lamina propris. IL-17 (Interleukin 17A) expressing CD4+T lymphocytes (Th17) cells naturally reside in the intestine's lamina propria where specific cytokines and microbiota, such as segmented filamentous bacteria (SFB), promote the differentiation. To…

Laure Bindels
Satheesh Natarajan, Ph.D., is a postdoctoral research fellow at the Laboratory of Biomedicine and Molecular Immunology, University of Veterinary Medicine and Pharmacy, in Kosice, Slovakia. His work is in immunology and molecular biology.

TH17 (T helper 17) has emerged as a novel potential therapeutic agent for the control of intestinal inflammatory conditions. These cells are most abundant in the small intestinal lamina propris. IL-17 (Interleukin 17A) expressing CD4+T lymphocytes (Th17) cells naturally reside in the intestine's lamina propria where specific cytokines and microbiota, such as segmented filamentous bacteria (SFB), promote the differentiation. To…

Laure Bindels
Satheesh Natarajan, Ph.D., is a postdoctoral research fellow at the Laboratory of Biomedicine and Molecular Immunology, University of Veterinary Medicine and Pharmacy, in Kosice, Slovakia. His work is in immunology and molecular biology.

Dr. Erika Isolauri is a professor of paediatrics at the University of Turku, and chief physician at the Department of Paediatrics at Turku University Hospital in Finland. At the 2014 Harvard Probiotics Symposium she presented a talk entitled Probiotic Use During Pregnancy for Protection Against Childhood Diseases. She sat down with Gut Microbiota for Health after the event to describe…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

Dr. Erika Isolauri is a professor of paediatrics at the University of Turku, and chief physician at the Department of Paediatrics at Turku University Hospital in Finland. At the 2014 Harvard Probiotics Symposium she presented a talk entitled Probiotic Use During Pregnancy for Protection Against Childhood Diseases. She sat down with Gut Microbiota for Health after the event to describe…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

The 2nd congress on targeting microbiota was held at Institut Pasteur in Paris on October 16-17, 2014. Professor Marvin Edeas, chairman of the scientific committee, warned the attendees about avoiding speculation where the challenge might be prevention instead of finding treatment. This should constitute a step "towards clinical revolution". To introduce this state of the art session, Pierre-Henri Gouyon, French National…

GMFH Editing Team
GMFH Editing Team

The 2nd congress on targeting microbiota was held at Institut Pasteur in Paris on October 16-17, 2014. Professor Marvin Edeas, chairman of the scientific committee, warned the attendees about avoiding speculation where the challenge might be prevention instead of finding treatment. This should constitute a step "towards clinical revolution". To introduce this state of the art session, Pierre-Henri Gouyon, French National…

GMFH Editing Team
GMFH Editing Team